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Abstract
Background: Reports of frequent manifestation of allergic diseases in children with attention deficit hyperactivity
disorder (ADHD) have been the subject of mounting clinical interest. However, evidence supporting the association
between ADHD and allergies is inconsistent and has yet to be systematically reviewed. The objective of this study
was to compile and assess available studies on the association between ADHD and allergic diseases in children.
Methods: A comprehensive search using MEDLINE, EMBASE, the Cochrane library, and CINAHL databases was
completed in 23 November 2015. The inclusion criteria for studies were that the research assessed allergic diseases
in children, 18 years of age and younger, with a diagnosis of ADHD and that a distinct comparison group was
incorporated. Any comparative studies, encompassing both randomized controlled trials and observational studies,
were considered for inclusion. Two review authors independently assessed the quality of the selected studies by
the use of validated assessment tools, performed data extraction and conducted meta-analysis according to
Cochrane Collaboration guidelines.
Results: Five eligible studies were included in this systematic review. Of these studies, three were case-control and
two were cross sectional studies. A majority of information from the five studies was classified as having low or
unclear risk of bias. The meta-analysis showed an association between children with ADHD and asthma compared
with the control groups (OR: 1.80, 95% CI: 1.57 - 2.07; five studies, low quality of evidence), but did not indicate an
association between food allergy and ADHD (OR: 1.13, 95% CI: 0.88 - 1.47; three studies very low quality of evidence).
The odds of experiencing allergic rhinitis, atopic dermatitis, and allergic conjunctivitis were slightly higher in children
with ADHD compared with control groups, though a substantial statistical heterogeneity was notable in the overall
effect estimates.
Conclusions: The findings from this review and meta-analysis show that children with ADHD are more likely to have
asthma, allergic rhinitis, atopic dermatitis, and allergic conjunctivitis than their counterparts. Interventions including
strategies for managing allergies in children with ADHD would be beneficial.
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Background
The association between attention deficit hyper disorder
(ADHD) and allergic diseases, whether rooted in comor-
bidity or causality, has been a source of public and clin-
ical concern since the 1980s [1]. The most recent
estimate of worldwide ADHD prevalence in children
and adolescents is reported at 7.1% [2]. ADHD is often
recognized in early-school children with persistent pat-
terns of inattention and hyperactivity-impulsivity that
interfere in functioning, social development or both and
the symptoms usually persist to adulthood [3]. There are
few therapy options (e.g., behavioral therapy or cognitive
training) for children with ADHD, but the effectiveness
varies depending on the individual because of the com-
plex array of factors (e.g., genetic and environmental
conditions) that intertwine with the behavioral interpret-
ation during their development [3, 4]. While a cure for
ADHD has not yet been fully achieved, the available
clinical treatment for children with ADHD, including
adolescents and adults, is largely medication-based (e.g.,
methylphenidate, amphetamine or atomoxetine adrener-
gic agonistics drugs), and the prescribed medications are
to improve certain aspects of attention span and hyper-
activity behavior [5].
Whether ADHD is related to hypersensitivity or not
has not been fully discerned, but numerous reports on
allergies in children with ADHD have created a growing
concern among healthcare providers. Several studies
have documented cases of allergic manifestations (e.g.,
atopic dermatitis or asthma) in response to stimulant
and non-stimulant drug treatments for ADHD, but the
explanation for the allergic disease manifestations
remained ambiguous [6–8]. In the aspect of the neuro-
physiological mechanism, some studies have suggested
that the relationship between the immune response and
the central nervous system (CNS) may predispose some
children to autism, impulsive behavior or ADHD [9–14].
However, the proposed interrelated mechanism of the el-
evated proinflammatory cytokines reactivity in the brain
found to be triggered by allergic response could does
not adequately explain the different types of allergy
manifested in the children with ADHD [15, 16]. With
environmental factors (e.g., family or school setting and
social distress) and other coexisting conditions (e.g.,
metabolic abnormalities, sleep disorders and epilepsy)
being suggested to influence the severity of ADHD
symptoms, it is necessary to gain a better understanding
of the relationship between allergy and ADHD from
both biological and epidemiological perspectives toward
providing the most desirable care possible [17, 18].
Several epidemiological studies have reported that
children with ADHD have a high risk of developing al-
lergic diseases, such as asthma and atopic dermatitis,
while other studies have reported no evidence of a link
between allergy and ADHD [19–22]. Given such con-
flicting evidence on the association, it is suspected that a
sizeable proportion of the ADHD population experien-
cing comorbidities with various allergic diseases may
have been overlooked. Moreover, the resulting lack of
clear recommendations in this area have meant that the
optimal benefit of tailored interventions and supportive
care may not reach those children in need. The objective
of this systematic review was thus to compile and
analyze the best available evidence on whether rates of
allergic diseases are significantly higher in children with
ADHD and to identify the specific types of allergic dis-
eases to which such children may be prone.
Methods
Search strategy
This review was conducted in accordance with the
Cochrane Handbook for Systematic Reviews and the
Preferred Reporting Items for Systematic reviews and
Meta-Analyses (PRISMA) statement, and the PRIMSA
checklist is provided in an additional file (see Additional
file 1) [23, 24]. A search strategy was developed, with an
information specialist, to meet the review question ‘Is
there an association between ADHD and allergies?’ and
the comprehensive search was completed on 23 Novem-
ber 2015 by the use of MEDLINE, EMBASE, the
Cochrane library and CINAHL databases. To ensure the
search was as comprehensive as possible, subject terms
were exploded so as to include narrower terms, regard-
less their wide range word expressions in the text search.
The search terms included ‘child development disorders,
pervasive’, ‘mental disorders diagnosed in childhood’, ‘at-
tention deficit disorder’, ‘learning disorder’, ‘autism’ and
‘hypersensitivity’ (see Additional file 2 for search strategy
details). There was no date, language or types of publica-
tion restriction imposed on the search. The retrieved ref-
erences and the articles were managed by the use of
EndNote version X6 software (Copyright © 2012 Thom-
son Reuters).
Study selection and quality assessment
Five authors reviewed titles and abstracts of all poten-
tially eligible articles retrieved from the databases. Three
authors in one group and two authors in another group
independently screened all the titles and abstracts from
the bibliographic list retrieved, and the reference lists of
the retrieved article were additionally hand-searched
where necessary. After irrelevant studies were removed
in this initial stage, two authors collected the full-text of
the potentially relevant studies and independently exam-
ined the report content for determining eligibility based
on our pre-specification criteria for including and ex-
cluding the studies. When studies referred to previously
published protocols or results reported elsewhere, those
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referenced studies were retrieved and examined as well.
After eligible studies had been selected, the studies were
then coded by the first author’s last name and publica-
tion year as their identification in this systematic review.
Any disagreement was resolved by discussion with other
authors or consultation with other experts in this
subject.
The eligibility criteria for including studies for this re-
view were developed by following the general methods
for Cochrane reviews and the Non-randomised Studies
Methods Group (NRSMG) of the Cochrane Collabor-
ation guidelines [23]. The participants that met this re-
view eligibility were children and adolescents who were
18 years of age or younger and were clinically diagnosed
or identified through psychiatric assessment as having
ADHD, and with the diagnosis of allergic diseases or im-
mune hypersensitivity. Mixed-gender studies, single-
gender studies and studies of ADHD-diagnosed children
with or without record of receiving treatment were eli-
gible for inclusion. The definition of ADHD was deter-
mined by the established Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition, Text Revi-
sion (DSM-IV-TR) and DSM-5, and the National Insti-
tute for Health and Care Excellence (NICE) clinical
guideline 72 on ADHD [25, 26]. In addition, studies that
referenced use of structured diagnostic interviews and
validated screening tools (e.g., Conners Parent Rating
Scale (CPRS) or Child Behavior Checklist (CBCL) scales)
in evaluating ADHD symptoms were considered eligible
for inclusion. In regard to the diagnosis of allergic dis-
eases, studies were considered for inclusion if the diag-
nosis was done under physical examination or
laboratory test, or otherwise met the clinical criteria for
the diagnosis of allergy (e.g., International Classification
of Disease, Injuries, and Causes of Death [ICD]). There
was no restriction placed on the types of study design
included. Randomized controlled trials and all compara-
tive studies (e.g., prospective, longitudinal, retrospective,
case-control or cross sectional studies) with a compari-
son group of children without clinical indication of de-
velopmental disorders were all considered eligible for
this review.
The exclusion criteria were studies that reported pre-
specified comorbidities within other categories of devel-
opmental disorders (e.g., autism spectrum disorders or
specific learning disabilities) or neurological disorders,
such as epilepsy. Finally, studies that included only adult
population, studies without distinguishable comparison
groups, studies using animal models, systematic reviews,
case series reports, and articles that did not provide ori-
ginal data were considered irrelevant for inclusion.
To appraise the validity of the studies, two authors
used risk of bias tools to perform quality and risk of bias
assessment for all the eligible studies independently. The
Cochrane risk-of-bias assessment tool was used to assess
clinical trial studies, and the Risk of Bias Assessment
Tool for Non-randomized Studies (RoBANS), equivalent
to that of the Cochrane risk-of-bias assessment tool, was
used to assess the observational studies [27]. There were
six main domains for potential bias evaluation in
RoBANS and each domain was categorized as ‘low risk’,
‘high risk’, or ‘unclear risk’. The methodological quality
of the primary studies were examined and judged as ei-
ther low, high or unclear risk of bias in relation to the
assessment domains. To enhance consistency of judg-
ment and decision making between the review authors,
we additionally referred to the guidance from the
Cochrane Risk of Bias Assessment Tool: for Non-
Randomized Studies of Interventions (ACROBAT-NRSI)
that described the types of bias for selection of partici-
pants, confounding, measurement of interventions,
measurement of outcomes, missing data and selection of
reported results for clarification [28]. After the risk of
bias assessment was completed, both authors independ-
ently extracted the data from the eligible primary studies
and recorded the extracted data to a modified data col-
lection form with items of required information listed.
The information items were consistent with our pre-
specified criteria and were formatted to seek for the
characteristic of the studies, setting, definition of the
ADHD population, types of allergy and results of any
outcome measures. The extracted data were then trans-
ferred to the Review Manager (RevMan) 5.3 software for
meta-analysis [29].
Data synthesis
Studies with similar characteristic were combined for
meta-analysis. When relevant outcome data were avail-
able for synthesis, they were entered into RevMan 5.3
software for pair-wise comparison. The Mantel-Haenszel
method was used for assessing dichotomous outcomes,
whereas for continuous outcomes, the inverse variance
method would be used. The relative effect measures
were calculated by using odds ratio (OR) statistics based
on the reporting from the studies, and the relative effect
estimate was assigned with a 95% confidence interval
(CI) and a p-value cut-off point of 0.05. Since diagnosis
tools used to assess ADHD were highly varied among
the studies due to cultural and clinical practice differ-
ences across countries, the true effect would be most
likely varied from one study to the next. For this reason,
a random-effects model assumption was used. If the
number of included studies was very small or the study
designs were too diverse, both random-effects and fixed-
effects models were used to test the trend of the esti-
mated effect as well. To determine heterogeneity, the
chi-squared method was used with a cut-off point of
0.10 to determine statistical significance. The I2 statistic
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was used to calculate consistency for the combined stud-
ies to test the impact of heterogeneity in the meta-
analysis. When the reason for substantial heterogeneity
was unclear, subgroup analysis was performed as a
means of investigating heterogeneous results and identi-
fying whether the difference between groups could have
interaction to the effect magnitude. The sensitivity ana-
lysis was performed to examine whether the overall esti-
mate in the meta-analysis was affected by studies
that were different in their sampling approach (e.g.,
population-based designs as opposed to hospital, school,
or community-based designs) or not.
Grading of evidence
To evaluate the quality of available data on the associ-
ation between ADHD and allergy diseases, the Grading
of Recommendations Assessment, Development and
Evaluation (GRADE), supported by guidelines outlined
in the GRADE handbook was used [30]. The strength of
the evidence were divided into four quality grades: high,
moderate, low, and very low, according to confidence in
the estimate lying close to the true effect [31]. Determi-
nations of quality were based on five factors: methodo-
logical limitations creating risk of bias within the study,
inconsistency of results, indirectness of evidence, impre-
cision of results, and publication bias. Quality ratings for
observational studies began from ‘low’, with the possibil-
ity of upgrading if further research would be likely to
provide confidence in the estimate effect or no threats
to validity and evidence of a dose-response or exposure-
response gradient were found. Studies were downgraded
as ‘very low’ quality if they contained uncertainty about
the directness of results or contained unsystematic ob-
servations [32].
Results
The comprehensive search identified a total of 261 studies
from the databases (Fig. 1). After removing duplicates, 240
studies were screened by title and abstracts for potential
inclusion. Out of 240 studies, 21 studies were selected for
full-text examination. Of those 21 studies, 15 studies did
not meet the entry criteria and were excluded with rea-
sons provided (e.g., twin studies, studies with no specified
comparison group or behavior assessments were made ac-
cording to the allergic severity and not by ADHD clinical
diagnoses; see Additional file 3 for details on excluded
studies with reasons for exclusion). There were multiple
reports of the same population identified and they were
considered as one study for meta-analysis, but those mul-
tiple reports that showed to have overlapping results, only
the study with the most relevant and high-quality data
among the reports were selected for inclusion. There were
no eligible RCT studies identified related to ADHD and al-
lergies. After the final selection process, five studies, all
observational in their study design, were found to meet
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Fig. 1 Flow diagram for search process and selection of studies
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a population-based case-control study [33], two were
case-control studies [34, 35], and two were cross sectional
studies [36, 37] (Table 1). These studies were conducted
in Germany, Korea, the United Kingdom (UK), Taiwan,
and Thailand with varied data sources. Among these stud-
ies, one study [35] collected data from hospital patients
and one study [36] collected data from the elementary
schools. The remaining three studies collected data from
national medical research databases: one study [33] used
National Health Insurance Research Database (NHIR),
one study [34] used UK General Practice Research Data-
base (GPRD) and one study [37] used German Health
Interview and Examination Survey for Children and Ado-
lescents. Among the five included studies, only one study
[34] indicated that children with ADHD had at least one
record of a methylphenidate prescription within 12 moths
after the date of first diagnosis. The rest of the four studies
did not include background information regarding pre-
scribed medications.
Of the five included studies, four studies [33–35, 37]
were judged to have an unclear risk of bias and only one
study [36] was judged to have a high risk of bias for se-
lective outcome reporting based on RoBANS criteria
(see Additional file 4 for the risk of bias assessment).
With regard to the selection of participants, four studies
were at unclear risk of bias [33, 34, 36, 37] whereas one
study was at low risk of bias [35]. As for potential bias
due to confounding, all studies were judged to have a
low risk of bias. Regarding to measurement of exposure,
four studies were at low risk of bias [33–35, 37] and one
study was at unclear risk of bias [36]. In the blinding of
outcome assessment domain, one study was at low risk
of bias [37] but the rest of the four studies were at un-
clear risk of bias. All the studies were at low risk of bias
in terms of bias caused by incomplete of outcome data.
As for selective outcome reporting, two studies were at
unclear risk of bias [33, 34], one study was at high risk
of bias [36], and two studies were at low risk of bias [35,
37]. Further details on the supporting judgments for risk
of bias assessments are presented in Additional file 4.
There was a total of 61,811 children involved in the five
included studies and 38,324 (62%) of the children were
males. Of the 61,811 children, 7937 (13%) were diagnosed
with ADHD. The types of allergic diseases reported in
these studies were asthma, allergic rhinitis, atopic derma-
titis, and allergic conjunctivitis. Other allergies such as
food allergy, drug allergy, urticatia, any atopic disorder or
unspecified allergies were also reported in some studies
(see Additional file 5 for a summary of results on allergic
diseases in children with ADHD). In performing the
meta-analysis, studies were stratified by their sample se-
lection approach as part of the sensitivity analysis. Two
studies [33, 37] were of population-based design and they
were grouped as (nationwide studies). As for the
remaining three studies [34–36], the data were collected
from selected schools or hospitals; wherefore, it was
grouped as (institutional-based studies).
Asthma
Five studies examined the risk of asthma in children
with ADHD compared to children without ADHD (Fig.
2a). The meta-analysis showed that children with ADHD
were nearly twice as likely to have asthma compared
with those in the control groups (OR: 1.80, 95% CI: 1.57
- 2.07, I2 = 60%; five studies, n = 59,646 children). The
pooled estimate from the studies showed a statistically
significant difference between the two groups, and the
large overall estimate indicated an association between
asthma and ADHD. The heterogeneity across the studies
was found to be statistically non-significant but a moder-
ate inconsistency was detected. To explore the influence
of nationwide studies versus institutional-based studies
on the effect estimate, subgroup analysis was conducted.
There was no significant difference found between the
nationwide studies [33, 37] and the institutional-based
studies [34–36].
Allergic rhinitis
Five studies evaluated the risk of allergic rhinitis in chil-
dren with ADHD compared to those without ADHD
(Fig. 2b). The result from the combined studies showed
that a higher proportion of children in the ADHD
groups had allergic rhinitis compared to the control
groups (OR: 1.59, 95% CI: 1.13 - 2.23, I2 = 93%; five
studies, n = 59,646 children). This suggests that children
with ADHD experienced 59% greater odds of having al-
lergic rhinitis relative to the children without ADHD;
however, substantial evidence of heterogeneity and in-
consistency were detected among the studies. Regarding
to subgroup analysis, there was no significant difference
indicated between the nationwide studies [33, 37] and
the institutional-based studies [34–36].
Atopic dermatitis
Five studies assessed the association between atopic
dermatitis and ADHD in children (Fig. 2c). From the
pooled estimated across the studies, the relative effect
indicated a significant difference between the ADHD
and the control groups, with cosiderable heterogeneity
and inconsistency found across the studies (OR: 1.43,
95% CI: 1.09 -1.88, I2 = 87%, five studies, n = 59,646). In
the subgroup analysis, an apparent difference was de-
tected (p = 0.006). The nationwide studies [33, 37]
showed that the children in the ADHD groups had
higher odds of atopic dermatitis relative to the control
groups (OR: 1.74, 95% CI: 1.36 - 2.22, I2 = 79%; two
studies, n = 51,033 children), and there was a substantial
heterogeneity and inconsistency found between the
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studies. From the institutional-based studies [34–36],
the odds of atopic dermatitis appeared to be only slightly
higher in the ADHD groups compared with the control
groups (OR: 1.16, 95% CI: 1.00 - 1.35, I2 = 0%; three
studies, n = 8613 children), and the effect estimate did
not reach statistical significance as the confidence inter-
val crossed the line of null effect.
Allergic conjunctivitis
Three studies provided data for allergic conjunctivitis in
children with ADHD compared with children without
ADHD (Fig. 2d). The pooled estimate from these studies
showed that a higher proportion of children in the ADHD
groups experienced allergic conjunctivitis compared with
the control groups (OR: 1.69, 95% CI: 1.04 - 2.76;
I2 = 92%, three studies, n = 41,908); however, there was
notable heterogeneity and a substantial inconsistency de-
tected across the studies. Differences between the sub-
groups, meanwhile were not statistically significant.
Food allergy
Three studies examined the association between ADHD
and food allergy; all of which were institutional-based
studies (Fig. 2e). The meta-analysis showed no signifi-
cant difference between the ADHD groups and the con-
trol groups, as the confidence interval of the odds ratio
estimate included the the null value (OR: 1.13, 95% CI:





Fig. 2 Forest plots of allergic diseases in children with ADHD and in control children. a Asthma. b Allergic. c Atopic dermatitis. d Allergic
conjunctivitis. e Food allergy.
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no implication of inconsistency and heterogeneity be-
tween the studies in the pooled result.
Quality of evidence
The quality of evidence for asthma associated with
ADHD in children was considered low quality, largely
due to information from one study [36] contributing a
serious risk of bias, thus posing a major threats to the
validity of information derived from the studies (Table
2). As for allergic rhinitis, atopic dermatitis, allergic con-
junctivitis and food allergy, the quality of the evidence
was downgraded from low to very low for serious risk of
bias and inconsistency between the included studies. De-
tails on the specific factors, such as overall risk of bias,
inconsistency, indirectness, imprecision and publication
bias, that influenced the evidence quality are described
in the summary of evidence quality table, based on the
GRADE approach (see Additional file 6). Publication
bias assessment was considered to be inappropriate since
only five studies were identified in this review. As a test
for funnel plot symmetry should ideally include at least
ten studies, the test for publication bias was not ad-
equately powered to determine whether this was truly
an issue in our analyses.
Discussion
This systematic review was designed to compile and
present the best available evidence for the association
between children with ADHD and allergic diseases in
children - a relationship hitherto not yet addressed in a
randomized controlled trial. Our meta-analysis of the
identified observational studies indicated that children
with ADHD have an 80% increased odds of asthma com-
pared with children without ADHD. The high asthma
rate in children with ADHD could potentially be linked
to the recent discovery of genetic association, in which
several studies suggested that a gene polymorphism of
dopamine receptor D5 (DRD5), a form of the dopamine
D1-like receptor, is associated with a ADHD behavior
subtype and that the expression of DRD5 is found in
both the mammalian brain and peripheral blood leuko-
cytes [38–40]. According to these reports, DRD5 may
also engage in some part of the immunological regula-
tion process of T helper 17 cell (Th17) differentiation,
which is extensively involved in asthma development
[41]. Available literature thus seemingly supports the
possible comorbidity of ADHD and asthma, but the cor-
relation between these multiple mechanisms has not yet
been clarified.
For allergic rhinitis, atopic dermatitis, and allergic
conjunctivitis, the estimated relative odds were
slightly higher in children with ADHD than in chil-
dren without ADHD. The low statistical power most
likely resulted from the statistical heterogeneity and
the methodological diversity of the included studies,
with a further potential confounder in factors that
were not measured (e.g., climate, pollution or micro-
bial agents). Since allergic rhinitis and conjunctivitis
are triggered by seasonal or household allergens, in-
sufficient covariate adjustment from the primary stud-
ies could yield heterogeneity in the meta-analyses; for
example, cross sectional data may have been collected
during a period when particular allergens are natur-
ally more prevalent [42]. Although the overall odds
ratio for atopic dermatitis was deemed small, the na-
tionwide studies from the subgroup analysis showed a
significantly higher rate of atopic dermatitis in chil-
dren with ADHD than in the control groups, and
interestingly, the estimate was similar to the result for
asthma. In line with that observation, a recent study
of atopic dermatitis reported that there was a high
frequency of filaggrin (FLG) null alleles detected in
children of European origin with both atopic derma-
titis and asthma phenotype [43, 44]. Perhaps it would
be advantageous to more closely examine in future
studies the comorbidity of atopic allergies and asthma
in children with ADHD, particularly, whether the al-
lergic march, in terms of the progression of various
allergic conditions with age, and genetic penetrance
could be a potential link.
Regarding to food allergy, there was no significant dif-
ference found between children with ADHD and chil-
dren in the control groups. One underlying reason for
this could be the complexity of the Immunoglobulin E
(IgE) immune response to food allergens in the gastro-
intestinal tract falling between the tolerance and
sensitization mechanisms [45]. In line with the present
findings, a previous systematic review similarly found no
evidence for an association between serum-IgE levels
and ADHD symptoms [20]. Although the complex gen-
etic associations between ADHD and immunological
regulations in the CNS have been emphasized in this re-
view, considering the onset and the vast array of neuro-
psychiatric disorder outcomes, neuronal signaling and
immune regulation thus represented only a small part of
the pathogenesis [10, 46].
The overall quality of evidence for an association be-
tween allergic diseases and ADHD children was found to
be low for asthma and very low for atopic dermatitis, aller-
gic rhinitis, allergic conjunctivitis, and food allergy. The
differences of study designs and studies with risk of bias
were largely attributed to the downgrading of the quality.
Perhaps more case-control studies with standardized pro-
tocols could allow for better effect estimation and
minimize the risk of bias posed in observational studies,
thus improving the validity of meta-analyses in future.
This review provides a summary of the overall level
of evidence for an association between ADHD and
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allergies. However, certain limitations should be con-
sidered when interpreting this review. The evidence
from these studies pertains only to the association be-
tween ADHD and allergies under the speculation of
possibly coexisting conditions and not on the onset
and the causative pathways between the two condi-
tions. Furthermore, this review was not able to obtain
information on the stimulant or non-stimulant
medication used in the ADHD population, except for
in one study [34], where the author mentioned that
the children with ADHD had at least one prescription
record of methylphenidate. Since that study excluded
those who did not used methylphenidate from the as-
sessment, a comparison group was not available for
analysis, and the evidence of an association between
stimulant used for ADHD and allergies remains
Table 2 Summary of findings
Allergy diseases in children with ADHD
Population: Children with ADHD
Setting: Germany, Korea, Taiwan, Thailand, UK
Intervention: none (observation of the difference in risk of allergy diseases)
Comparison: Children without ADHD
Outcome: Allergic diseases









Asthma 125 per 1000 205 per 1000 (183 to 228) OR 1.80 (1.57 to 2.07) 59,646 (5 studies) ⨁⨁◯◯ LOW a,h
a) Nationwide studies a) 71 per 1000 a) 130 per 1000 (113 to 149) a) OR 1.96 (1.67 to 2.30) a) 51,033 (2 studies) a) ⨁◯◯◯ VERY LOW b,h
b) Institutional-based
studies
b) 241 per 1000 b) 347 per 1000 (320 to 374) b) OR 1.67 (1.48 to 1.88) b) 8613 (3 studies) b) ⨁◯◯◯ VERY LOW c.h
Allergic rhinitis 153 per 1000 222 per 1000 (169 to 286) OR 1.59 (1.13 to 2.23) 59,646 (5 studies)
a)
⨁◯◯◯ VERY LOW a,d,e,h
a) Nationwide studies a) 134 per 1000 a) 205 per 1000 (129 to 312) a) OR 1.67 (0.96 to 2.93) b) 51,033 (2 studies) a) ⨁◯◯◯ VERY LOW b,d,e,h
b) Institutional-based
studies
b) 325 per 1000 b) 416 per 1000 (325 to 511) b) OR 1.48 (1.00 to 2.17) c) 8613 (3 studies) b) ⨁◯◯◯ VERY LOW c,d,e,h
Atopic dermatitis 100 per 1000 137 per 1000 (108 to 173) OR 1.43 (1.09 to 1.88) 59,646 (5 studies) ⨁◯◯◯ VERY LOW a,d,h
a) Nationwide studies a) 94 per 1000 a) 154 per 1000 (124 to 188) a) OR 1.74 (1.36 to 2.22) a) 51,033 (2 studies) a) ⨁◯◯◯ VERY LOW b,d,h
b) Institutional-based
studies
b) 100 per 1000 b) 114 per 1000 (100 to 130) b) OR 1.16 (1.00 to 1.35) b) 8613 (3 studies) b) ⨁◯◯◯ VERY LOW c,h
Allergic Conjunctivitis 203 per 1000 301 per 1000 (210 to 413) OR 1.69 (1.04 to 2.76) 41,908 (3 studies) ⨁◯◯◯ VERY LOW c,d,e,h
a) Nationwide studies a) 203 per 1000 a) 347 per 1000 (333 to 360) a) OR 2.08 (1.96 to 2.21) a) 37,715 (1 study) a) ⨁⨁◯◯ LOW f
b) Institutional-based
studies




75 per 1000 84 per 1000 (67 to 106) OR 1.13 (0.88 to 1.47) 8613 (3 studies) ⨁◯◯◯ VERY LOW c,e,h
*The risk in the ADHD group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the exposure (and
its 95% CI)
CI confidence interval, OR odds ratio
GRADE Working Group grades of evidence (level of evidence of grading for observational studies)
Very low: Observational studies with uncertainty about the directness of results or unsystematic observations
Low: Observational studies with no threats to validity
Moderate: Observational studies with no threats to validity and evidence of a dose-response or exposure-response gradient
High: Observational studies with no threats to validity yielding very large effects
a Four of the studies had limitation on the selection of participants and blinding of outcomes assessments by their study designs but one study had unclear risk
of bias in the measurement of exposure and one study indicated high risk of bias on the outcome reporting which lowered the quality of the
observational evidence
b The proportion of information was from two studies indicated with limitation on selection of participants and blinding by their study designs but the unclear
risk of selective reporting which lowered the quality of the observational evidence
c The proportion of information was from two studies indicated limitation on selection of participants and blinding of outcome assessments by their study
designs but one study had high risk of outcome reporting, which lowered the quality of the observational evidence
d There is an indication of significant inconsistency (I2 > 80%)
e Information were from high heterogeneity and small sample size with a wide confidence interval
f The information is based on one study, which had limitation on the selection of participants, blinding of outcomes assessments and selective outcome reporting
by the study design
g The information from two studies that had limitation on selection of participants, measurement of exposure, blinding of outcome assessment by their study
designs but one with high risk of bias on selective outcome reporting which lowered the quality of the observational evidence
h The possibility of publication bias is not disregarded but it was not considered to downgrade the quality of the observational evidence
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lacking. In several of the identified studies [33, 34,
37], the control group of children was selected based
on the absence of ADHD medical records with one
study excluded female children; therefore, potential
ADHD cases in the control group were not consid-
ered. With a small sample size in one study, an over-
estimation of power for the pooled standardized mean
could likely influence the magnitude of the observed
relationships between ADHD and allergic diseases. To
enhance the quality of evidence, the presence of po-
tential confounding factors in terms of cognitive abil-
ity, family environment (e.g., parents’ mental health,
parenting attitudes), and other potential coexisting
mental diseases (e.g., anxiety disorder, major depres-
sive disorder, autism spectrum disorder) should be
elucidated. Additionally, medication sensitivity, bacter-
ial or fungal infection and preterm birth should also
be adequately identified and adjusted for in analyses.
Conclusions
This systematic review showed that children with
ADHD had elevated rates of asthma compared to the
children without ADHD. An association between food
allergy and ADHD, meanwhile, was not evident based
on the meta-analysis. The odds of allergic rhinitis,
atopic dermatitis, and allergic conjunctivitis in chil-
dren with ADHD was found to be slightly higher than
in children without ADHD, though the overall effect
size was affected by substantial heterogeneity across
the studies. Interventions incorporating strategies that
focus on allergic disease management and collabora-
tive care for children with ADHD might be beneficial
to explore.
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